Patents by Inventor Maithili Rairkar

Maithili Rairkar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Implantable Drug Delivery Devices For Localized Drug Delivery
    Publication number: 20240100010
    Abstract: Provided herein are drug implants comprising a therapeutically active agent for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and a therapeutically active agent disposed therein. Additionally, provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may comprise bicalutamide, e.g., for use in the treatment of prostate cancer.
    Type: Application
    Filed: December 18, 2020
    Publication date: March 28, 2024
    Inventors: Carlos Schuler, Maithili Rairkar, Pujan Desai, Maxime Daud, Maxime D. Rappaport, Pamela Munster, John Maroney, Margaret McLaughlin, Tobias H. Casab, Keith Hall, Scott Thomas
  • Drug Implants Containing Darolutamide and Methods of Use Thereof
    Publication number: 20240033249
    Abstract: Provided herein are drug implants comprising Darolutamide for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and Darolutamide disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may be used for the treatment of a proliferative disease of the prostate.
    Type: Application
    Filed: July 19, 2023
    Publication date: February 1, 2024
    Inventors: Maithili Rairkar, Pujan Desai, Pamela Munster, Scott Thomas
  • Drug Implants Containing Apalutamide and Methods of Use Thereof
    Publication number: 20240016731
    Abstract: Provided herein are drug implants comprising apalutamide for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and apalutamide disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may be used for the treatment of a proliferative disease of the prostate.
    Type: Application
    Filed: September 27, 2021
    Publication date: January 18, 2024
    Inventors: Maithili Rairkar, Pujan Desai, Carlos Schuler, Keith Hall, Pamela Munster, John Maroney
  • DRUG IMPLANTS CONTAINING ENZALUTAMIDE AND METHODS OF USE THEREOF
    Publication number: 20230255883
    Abstract: Provided herein are drug implants comprising enzalutamide for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and enzalutamide disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may be used for the treatment of a proliferative disease of the prostate.
    Type: Application
    Filed: April 25, 2023
    Publication date: August 17, 2023
    Inventors: Maithili Rairkar, Pujan Desai, Carlos Schuler, Keith Hall, Pamela Munster, John Maroney, Scott Thomas
  • Drug implants containing enzalutamide and methods of use thereof
    Patent number: 11666528
    Abstract: Provided herein are drug implants comprising enzalutamide for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and enzalutamide disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may be used for the treatment of a proliferative disease of the prostate.
    Type: Grant
    Filed: April 25, 2022
    Date of Patent: June 6, 2023
    Assignees: The Regents of the University of California, Alessa Therapeutics, Inc.
    Inventors: Maithili Rairkar, Pujan Desai, Carlos Schuler, Keith Hall, Pamela Munster, John Maroney, Scott Thomas
  • DRUG IMPLANTS CONTAINING ENZALUTAMIDE AND METHODS OF USE THEREOF
    Publication number: 20230080240
    Abstract: Provided herein are drug implants comprising enzalutamide for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and enzalutamide disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may be used for the treatment of a proliferative disease of the prostate.
    Type: Application
    Filed: April 25, 2022
    Publication date: March 16, 2023
    Inventors: Maithili Rairkar, Pujan Desai, Carlos Schuler, Keith Hall, Pamela Munster, John Maroney, Scott Thomas
  • Implantable drug delivery devices for localized drug delivery
    Patent number: 11344526
    Abstract: Provided herein are drug implants comprising a therapeutically active agent for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and a therapeutically active agent disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may comprise bicalutamide, e.g., for use in the treatment of prostate cancer.
    Type: Grant
    Filed: March 20, 2020
    Date of Patent: May 31, 2022
    Assignees: The Regents of the University of California, Alessa Therapeutics, Inc.
    Inventors: Maithili Rairkar, Pujan Desai, Carlos Schuler, Maxime Daud, Maxime D. Rappaport, Pamela Munster, John Maroney, Margaret McLaughlin, Tobias H. Casab, Keith Hall, Scott Thomas
  • Implantable drug delivery devices for localized drug delivery
    Patent number: 11338119
    Abstract: Provided herein are drug implants comprising a therapeutically active agent for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and a therapeutically active agent disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may comprise bicalutamide, e.g., for use in the treatment of prostate cancer.
    Type: Grant
    Filed: March 20, 2020
    Date of Patent: May 24, 2022
    Assignees: The Regents of the University of California, Alessa Therapeutics, Inc.
    Inventors: Maithili Rairkar, Pujan Desai, Carlos Schuler, Maxime Daud, Maxime D. Rappaport, Pamela Munster, John Maroney, Margaret McLaughlin, Tobias H. Casab, Keith Hall, Scott Thomas
  • Implantable drug delivery devices for localized drug delivery
    Patent number: 11173291
    Abstract: Provided herein are drug implants comprising a therapeutically active agent for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and a therapeutically active agent disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may comprise bicalutamide, e.g., for use in the treatment of prostate cancer.
    Type: Grant
    Filed: March 20, 2020
    Date of Patent: November 16, 2021
    Assignees: The Regents of the University of California, Alessa Therapeutics, Inc.
    Inventors: Maithili Rairkar, Pujan Desai, Carlos Schuler, Maxime Daud, Maxime D. Rappaport, Pamela Munster, John Maroney, Margaret McLaughlin, Tobias H. Casab, Keith Hall, Scott Thomas
  • Implantable Drug Delivery Devices for Localized Drug Delivery
    Publication number: 20210290920
    Abstract: Provided herein are drug implants comprising a therapeutically active agent for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and a therapeutically active agent disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may comprise bicalutamide, e.g., for use in the treatment of prostate cancer.
    Type: Application
    Filed: March 20, 2020
    Publication date: September 23, 2021
    Inventors: Maithili Rairkar, Pujan Desai, Carlos Schuler, Maxime Daud, Maxime D. Rappaport, Pamela Munster, John Maroney, Margaret McLaughlin, Tobias H. Casab, Keith Hall, Scott Thomas
  • Implantable Drug Delivery Devices for Localized Drug Delivery
    Publication number: 20210290584
    Abstract: Provided herein are drug implants comprising a therapeutically active agent for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and a therapeutically active agent disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may comprise bicalutamide, e.g., for use in the treatment of prostate cancer.
    Type: Application
    Filed: March 20, 2020
    Publication date: September 23, 2021
    Inventors: Maithili Rairkar, Pujan Desai, Carlos Schuler, Maxime Daud, Maxime D. Rappaport, Pamela Munster, John Maroney, Margaret McLaughlin, Tobias H. Casab, Keith Hall, Scott Thomas
  • IMPLANTABLE DRUG DELIVERY DEVICES FOR LOCALIZED DRUG DELIVERY
    Publication number: 20210290919
    Abstract: Provided herein are drug implants comprising a therapeutically active agent for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and a therapeutically active agent disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may comprise bicalutamide, e.g., for use in the treatment of prostate cancer.
    Type: Application
    Filed: March 20, 2020
    Publication date: September 23, 2021
    Inventors: Maithili Rairkar, Pujan Desai, Carlos Schuler, Maxime Daud, Maxime D. Rappaport, Pamela Munster, John Maroney, Margaret McLaughlin, Tobias H. Casab, Keith Hall, Scott Thomas
  • Pulmonary surfactant formulations
    Patent number: 8337815
    Abstract: Synthetic pulmonary surfactant compositions comprising dipalmitoyl phosphatidylcholine, phosphatidylglycerol, and essentially neutral lipid, and having essentially no 1-palmitoyl 2-oleoyl phosphatidylglycerol and essentially no palmitic acid are provided. Methods for treating respiratory disease are also provided comprising administering a therapeutically effective amount of a synthetic pulmonary surfactant comprising dipalmitoyl phosphatidylcholine, phosphatidylglycerol, and essentially neutral lipid, and having essentially no 1-palmitoyl 2-oleoyl phosphatidylglycerol and essentially no palmitic acid.
    Type: Grant
    Filed: December 21, 2005
    Date of Patent: December 25, 2012
    Assignee: Discovery Laboratories, Inc.
    Inventors: Maithili Rairkar, Rom E Eliaz, Ralph Niven, Mark E. Johnson
  • Pulmonary surfactant formulations
    Publication number: 20060286038
    Abstract: Synthetic pulmonary surfactant compositions comprising dipalmitoyl phosphatidylcholine, phosphatidylglycerol, and essentially neutral lipid, and having essentially no 1-palmitoyl 2-oleoyl phosphatidylglycerol and essentially no palmitic acid are provided. Methods for treating respiratory disease are also provided comprising administering a therapeutically effective amount of a synthetic pulmonary surfactant comprising dipalmitoyl phosphatidylcholine, phosphatidylglycerol, and essentially neutral lipid, and having essentially no 1-palmitoyl 2-oleoyl phosphatidylglycerol and essentially no palmitic acid.
    Type: Application
    Filed: December 21, 2005
    Publication date: December 21, 2006
    Inventors: Maithili Rairkar, Rom Eliaz, Ralph Niven, Mark Johnson
  • Methods, systems and devices for delivery of pulmonary surfactants
    Publication number: 20060120968
    Abstract: The invention is directed to methods, systems and devices for pulmonary delivery of aerosolized active agents in combination with positive pressure ventilation therapy and methods of treating respiratory dysfunction.
    Type: Application
    Filed: August 22, 2005
    Publication date: June 8, 2006
    Inventors: Ralph Niven, Wiwik Watanabe, Matthew Thomas, David Brown, Mark Johnson, Maithili Rairkar
  • Methods, systems and devices for noninvasive pulmonary delivery
    Publication number: 20060078506
    Abstract: The invention is directed to noninvasive methods, systems and devices for pulmonary delivery of aerosolized active agents and methods of treating respiratory dysfunction.
    Type: Application
    Filed: May 17, 2005
    Publication date: April 13, 2006
    Inventors: Ralph Niven, Wiwik Watanabe, Matthew Thomas, David Brown, Mark Johnson, Maithili Rairkar